Inhibition of mTOR signaling to activate TFEB-mediated lysosomal biogenesis and autophagy, leads to clearance of Aβ and tau, and improvement of cognitive function in AD animal models [86-88]. The gene discussed is MAPT; the disease is Alzheimer disease.